NASDAQ: QTTB

Q32 Bio Inc Stock Forecast, Predictions & Price Target

The consensus among 2 Wall Street analysts covering (NASDAQ: QTTB) stock is to Strong Buy QTTB stock.

Out of 2 analysts, 1 (50%) are recommending QTTB as a Strong Buy, 1 (50%) are recommending QTTB as a Buy, 0 (0%) are recommending QTTB as a Hold, 0 (0%) are recommending QTTB as a Sell, and 0 (0%) are recommending QTTB as a Strong Sell.

If you're new to stock investing, here's how to buy Q32 Bio stock.

(NASDAQ: QTTB) Q32 Bio's forecast annual revenue growth rate of 341.21% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Q32 Bio's revenue in 2024 is $1,156,000.On average, 1 Wall Street analysts forecast QTTB's revenue for 2028 to be $132,576,763, with the lowest QTTB revenue forecast at $132,576,763, and the highest QTTB revenue forecast at $132,576,763. On average, 1 Wall Street analysts forecast QTTB's revenue for 2029 to be $642,989,227, with the lowest QTTB revenue forecast at $642,989,227, and the highest QTTB revenue forecast at $642,989,227.

In 2030, QTTB is forecast to generate $1,380,510,045 in revenue, with the lowest revenue forecast at $1,380,510,045 and the highest revenue forecast at $1,380,510,045.

According to 2 Wall Street analysts that have issued a 1 year QTTB price target, the average QTTB price target is $47.50, with the highest QTTB stock price forecast at $50.00 and the lowest QTTB stock price forecast at $45.00.

On average, Wall Street analysts predict that Q32 Bio's share price could reach $47.50 by Apr 11, 2025. The average Q32 Bio stock price prediction forecasts a potential upside of 78.64% from the current QTTB share price of $26.59.

(NASDAQ: QTTB) forecast ROE is N/A, which is considered weak.